Together, these findings established a novel aspect of IDO1’s function in cancer, namely, its ability to contravene an anti-tumorigenic, IFNγ-mediated inflammatory environment that restricts new blood vessel formation in tumors. The gene discussed is IDO1; the disease is cancer.